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Research
AbstrACt
Objectives A systematic review of paediatric low-risk 
febrile neutropenia found that outpatient care is safe, with 
low rates of treatment failure. However, this review, and 
a subsequent meta-ethnography, suggested that early 
discharge of these patients may not be acceptable to key 
stakeholders. This study aimed to explore experiences 
and perceptions of patients, parents and healthcare 
professionals involved in paediatric febrile neutropenia 
care in the UK.
setting Three different centres within the UK, purposively 
selected from a national survey on the basis of differences 
in their service structure and febrile neutropenia 
management.
Participants Thirty-two participants were included in 
eight focus group discussions.
Primary outcomes Experiences and perceptions of 
paediatric febrile neutropenia care, including possible 
future reductions in therapy.
results Participants described a quest for certainty, in 
which they attempted to balance the uncertainty involved 
in understanding, expressing and negotiating risk with the 
illusion of certainty provided by strict protocols. Participants 
assessed risk using both formal and informal stratiication 
tools, overlaid with emotional reactions to risk and 
experiences of risk within other situations. The beneits of 
certainty provided by protocols were counterbalanced by 
frustration at their strict constraints. The perceived beneits 
and harms of previous inpatient care informed participants’ 
appraisals of future treatment strategies.
Conclusions This study highlighted the previously 
underestimated harms of admission for febrile neutropenia 
and the paternalistic nature of decision making, along with 
the frustrations and challenges for all parties involved in 
febrile neutropenia care. It demonstrates how the same 
statistics, generated by systematic reviews, can be used 
by key stakeholders to interpret risk differently, and how 
families in particular can view the harms of therapeutic 
options as different from the outcomes used within the 
literature. It justiies a reassessment of current treatment 
strategies for these children and further exploration of the 
potential to introduce shared decision making.
bACkgrOund 
Febrile neutropenia is the most common 
life-threatening complication of treatment 
for childhood cancer and carries a risk of 
sepsis, including intensive care admission 
and death.1 However, over 50% of children 
have no significant sequelae or clinically or 
microbiologically defined infection.2 3 Risk 
stratification tools may help distinguish those 
with high-risk febrile neutropenia from those 
with lower risk of significant complications, 
though it should be recognised that these 
tools have some challenges, and a univer-
sally agreed ‘gold standard’ tool has yet to 
be defined.3 Current treatment for children 
with febrile neutropenia in the UK consists 
of admission to hospital for at least 48 hours, 
with administration of empirical intravenous 
antibiotics.4 
It has been suggested that reducing therapy 
for children with low-risk febrile neutro-
penia could improve quality of life, reduce 
strengths and limitations of this study
 Ź This study involves new voices in the discussion 
of febrile neutropenia management, particularly 
healthcare professionals.
 Ź It speciically explored disease-speciic factors in-
volved in decision making about early discharge.
 Ź The inclusion of multiple centres allows for an un-
derstanding of service design and centre culture on 
participants’ perceptions.
 Ź Challenges related to the groups which proved difi-
cult to recruit, including young people and those who 
have a limited ability to communicate in English.
 Ź The small size of some of the focus groups may be 
considered a limitation by some. The implications of 
this are discussed further in the text.
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hospital acquired infections and reduce costs to health-
care.5–8 Our recent systematic review found that early 
discharge did not increase intensive care admissions or 
death, but did appear to increase the risk of readmission 
to hospital, from around 2.2% to 14%.9 Furthermore, 
there was a suggestion that reduced therapy options 
may not be acceptable to families and professionals as 
consent rates to the included trials were relatively low. 
Few other studies have explored family and professional 
preferences for location of therapy. In one study, inter-
views using a threshold technique found that just 53% of 
parents and 71% of professionals would choose outpa-
tient treatment for low-risk paediatric febrile neutro-
penia.10 A meta-ethnography of the existing qualitative 
literature surrounding early discharge revealed that there 
may be challenges surrounding practical logistics, and 
social or emotional issues, influenced by fear, timing and 
resources.11 However, the data focused almost exclusively 
on parental views, lacked exploration of the influence 
of healthcare settings and had little disease-specific data 
about febrile neutropenia.
This study spoke to patients, parents and healthcare 
professionals involved in paediatric low-risk febrile neutro-
penia, to build understanding about perceptions of early 
discharge and so inform future policy and practice. We 
aimed to explore the contextual features that might influ-
ence the experience of individual patients and families, 
including previous experiences of febrile neutropenia, 
family structure and background and healthcare service 
design and culture. This paper presents one of the key 
themes from the findings, with the remainder presented 
elsewhere, to enable richer explorations within the limits 
of article word counts.
MethOds
National Health Service Research Ethics Committee (ref 
15/YH0208) and study sites’ Research and Development 
approval was obtained prior to commencement of the 
research.
study site identiication and recruitment
Data from a recent UK survey were used to identify centres 
with different approaches to risk stratification, low-risk 
protocols, shared care services and geographical spread 
of patients.12 Three centres were purposively selected to 
enable investigation of the role of various centre-level 
factors and then approached through professional groups 
within the Children’s Cancer and Leukaemia Group.
Centres 1 and 2 both have around 25 inpatient beds at 
the primary treatment centres (PTCs) and see 100–150 
new cases of childhood cancer per year. Centre 1 has 
minimal care of febrile neutropenia in its shared care 
centres. Centre 2 has some shared care services, but the 
majority of cases of febrile neutropenia are managed 
in the PTC. Centre 3 treats over 160 new children per 
year and has more than 30 inpatient beds. They have a 
strong shared care network, and most low-risk febrile 
neutropenia is managed within Paediatric Oncology 
Shared Care Units (POSCUs).
Centres 1 and 3 closely followed the current National 
Institute for Health and Care Excellence (NICE) guide-
lines for febrile neutropenia.13 Centre 2 used a higher 
threshold to define fever and did not use a risk stratifica-
tion tool, although they were reviewing their policy. All 
centres’ protocols involved at least 48 hours admission 
with intravenous antibiotics for at least 24 hours.
The study opened to recruitment in July 2015, and the 
final focus group discussion took place in March 2016.
Identiication, recruitment and consent of participants
Four focus group discussions were planned in each study 
site, for each of: patients (aged 13–18 years), parents of 
teenagers (13–18 years), parents of younger children 
(under 13 years) and healthcare professionals (doctors 
and nurses working in paediatric haematology and 
oncology services). Families were invited if they were at 
risk of low-risk febrile neutropenia or within 6 months of 
being at risk, assessed by the modified Alexander rule.14 
This rule was chosen as it is the risk stratification tool 
advised by the UK’s NICE guidelines.13 Patients receiving 
palliative care alone were excluded. Parent–child dyads 
and parent couples were not explicitly recruited, but 
could be included.
Families were identified and invited to participate 
by their local team, then contacted by JEM to establish 
a relationship and answer further research questions. 
Healthcare professionals were invited through local team 
meetings and emails sent by the site-specific collaborator. 
Written consent was obtained. Participants had the right 
to withdraw at any point up to 2 weeks following the focus 
group discussion. Participants received travel expenses 
and a £20 Amazon voucher for their attendance at the 
group. This reflects INVOLVE guidance for participant 
remuneration.15
Focus group discussions
Each group had between 3 and 7 participants and lasted 
between 45 and 86 min (median 73 min). Focus groups 
were performed at a site suitable for participants, for 
most this was within the hospital building, but other 
facilities such as local library meeting rooms were also 
used. JEM, a Clinical Research Fellow, moderated all 
groups, with an assistant present. This study forms part 
of her PhD, and she has completed Level 7 training in 
focus group moderation and qualitative methodology. 
Participants were aware of the study’s aims and objec-
tives and of JEM’s research background. If directly asked, 
she confirmed her medical professional background. 
Focus group topic guides are included in online supple-
mentary resource 1. Encrypted digital audio record-
ings of each discussion were obtained, then transcribed 
and anonymised by JEM. A research journal was kept 
throughout.
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Analysis
This study used a constant comparison approach. Each 
transcript was individually coded by JEM with input 
from KA. No analytical software was used. At the intra-
group comparison stage, individual voices were followed 
through the focus groups to identify codes which occurred 
more frequently, or with different quality, dependent on 
the characteristics of individuals. Discussions were then 
compared with other groups of participants (healthcare 
professionals, parents of under 13 years, parents of teen-
agers and young people) and other centres. At this inter-
group stage, the triangulation of centres and participant 
groups was explicitly explored. The two stages were then 
overlaid to provide a network through which the general 
iterative themes were compared and mapped prior to 
representing the final framework. Following presenta-
tions of the findings, participants have confirmed that 
they agree with the analytical findings.
results
Participants
Thirty-two participants were included in eight focus 
group discussions. Four additional focus group discus-
sions were intended but were precluded by poor recruit-
ment of young people and parents of teenagers in centres 
2 and 3. Table 1 provides a summary of the focus groups 
performed at each centre, and table 2 provides a more 
detailed summary of the focus group compositions.
understanding, expressing and negotiating risk
In all centres, healthcare professionals struggled to cogni-
tively separate different febrile neutropenia risk groups, 
tending to think about children as having ‘febrile neutro-
penia’, rather than low-risk or high-risk episodes.
4: I think it’s just I’ve been here for an awful long 
time and that’s what we’ve done and I know it’s the 
small number of children that you can remember 
that just… that just do… collapse within less than 
8 hours…
Mod: without giving us patient identifiable data, 
could you describe one?
4: mm… oh God… erm… ermm… yeah probably the 
most vivid one was when I was over at [another hospi-
tal]… so I couldn’t even tell you the name of the pa-
tient… erm… but walked onto the ward having had 
a single fever at home… and within… within minutes 
we were resuscitating him…
1: but he wouldn’t be low risk would he?
4: he wouldn’t no but that’s the bit that I don’t know 
why but that’s the bit that sticks in my mind… (Centre 
1, nurse (4) and doctor (1))
It is not surprising that the healthcare professional 
participants had emotional responses to the idea of early 
discharge; generally anxiety or fear. One participant phys-
ically shivered at the mention of outpatient treatment:
1: it’s not like they won’t be febrile at home… they’d 
be going home febrile wouldn’t they (murmur of 
agreement) so then you’d have to work out what…
4: [4] shivered again!!! (laughter) (Centre 1, doctor 
(1) and nurse (4))
Parents and young people group participants were 
unfamiliar with formal risk stratification. Instead, parents 
employed their own methods to establish the dangers 
posed by an episode of febrile neutropenia. Partici-
pants differentiated episodes into those where the child 
appeared unwell, was not their usual self and caused 
the parents to worry from those in which the child had 
a fever but their behaviour did not otherwise concern 
their parents. As such, the idea of being ‘well’ or ‘unwell’ 
formed an instinctive risk stratification ‘tool’. Families 
envisaged that the management of these groups would be 
adapted according to the severity of ‘unwellness’.
When formal risk stratification tools were introduced 
into the parents’ focus group discussions, participants 
spoke about how clearly knowing whether their child was 
at low or high risk of significant complications facilitated 
their own decision making about preferred care.
2: …now that I know that you’ve said that he’s in a 
lower risk group then actually maybe I wouldn’t have 
panicked quite so much and thought you know… and 
if the option would have been there… I would have 
probably gone with it but not knowing that informa-
tion and… and just being told 38 degrees he’s got to 
go in and…. And I just follow protocol… I follow the 
rules… (Centre 1, parents of under 13 s)
This acceptance by parents of risk stratification as a 
concept and their current use of a similar assessment 
strategy suggests that increased communication of the 
level of a child’s risk may support shared decision making 
between families and healthcare professionals. Further-
more, explicitly stating the level of risk for a child may 
quieten the emotional responses that healthcare profes-
sionals have towards reduced therapy regimens.
The challenge of deciphering statistical evidence 
regarding risks was evident, even within the healthcare 
professional groups. In one group, misunderstandings 
about systematic review methodology and confusion 
over statistical issues, such as power, led to mistrust of the 
evidence.
Table 1 Summary of focus group discussions performed 
by centre
Healthcare 
professionals
Parents of 
patients aged 
under 13 years
Parents of 
patients aged 
over 13 years
Young 
people aged 
13–18 years
Centre 1
Centre 2
Centre 3
Green—focus group performed, red—focus group desired but precluded by 
poor recruitment.
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Table 2 Table of focus group composition
Location Group
Number of 
participants M:F ratio Age
Ethnicity (self-
deined) Composition notes
Centre 1 Young people 3 0:3 15–
16 years
3 White British Two participants with Hodgkin’s disease, one with ALL. One 
participant with no febrile neutropenia episodes, one with 
one low-risk episode, one with six high-risk episodes. All 
episodes treated at PTC (two episodes started at POSCU 
but transferred to PTC). No ICU admissions. One course 
of chemo delayed following high-risk episode. Admissions 
2–10 days (most 5–6 days).
Centre 1 Parents of under 
13 years
3 0:3 36–
43 years
3 White British All nuclear families with two children. Two  degree-level 
education, one GCSE level. All employed. Partners same 
educational and employment. Two own house, one rents 
privately.
Affected children aged 4–10 years. Two ALL, one 
medulloblastoma. Between 2–10 episodes of FN; 0–8 high-
risk episodes each, 1–2 low-risk episodes each. All managed 
at PTC. No ICU. One removal of line. One delayed course of 
chemo. Admissions 2–19 days (most 48–72 hours).
Centre 1 Parents of over 
13 years
5 2:3 41–
53 years
All White British Three nuclear families with 2–3 children. One blended family 
(both parents present), with three children. One degree-
level education, one A level, one ONC, two GCSE level. 
All employed except one who is semiretired (to care for 
child). Partners same educational and employment levels. 
All own house, four with mortgage. Four have children who 
participated in young people’s group.
Affected children 13–16 years old. Two with Hodgkin’s 
disease, one with ALL, one with relapsed ALL. One patient 
with no febrile neutropenia episodes, one with one low-
risk episode, one with six high-risk episodes, one with 
seven high-risk episodes and one low-risk episode. All 
episodes treated at PTC (two episodes started at POSCU 
but transferred to PTC). No ICU admissions. Two courses 
of chemo delayed following high-risk episodes. Admissions 
2–10 days (most 5–6 days).
Centre 1 Healthcare 
professionals
7 3:4 30–
51 years
6 White British, 1 
Chinese
Three medical (SHO, registrar and consultant), four nursing 
(bands 5–7). 1–13 years at current grade. 1–24 years at current 
centre.
Centre 2 Parents of under 
13 years
5 1:4 35–
44 years
All White British All nuclear families with 2–7 children. Two participants from 
same family. Three with degree-level education, two with O 
levels. One employed, four homemakers/carers. Partners—
one degree-level education, one A levels, one HNC, two 
with O levels. Two employed, one self-employed, two 
homemakers/carers. Three own house (two with mortgage), 
two rent privately.
Affected children 2–9 years old. Diseases relapsed Wilm’s 
tumour, ALL, osteosarcoma, ependymoma. 2–7 episodes 
of febrile neutropenia; 1–5 high-risk episodes each, 0–2 
low-risk episodes each. All but one managed in PTC. No 
ICU admissions. One course of chemo delayed. Admissions 
2–14 days (median 4 days).
Centre 2 Healthcare 
Professionals
3 0:3 43–
60 years
1 White British, 1 
Indian (British), 1 
Pakistani
Two medical (registrar, consultant), one nursing. 
7 months–20 years at current grade. 7 months–28 years at 
current centre.
Centre 3 Parents of under 
13 years
3 0:3 36–
45 years
All White British Two nuclear families with two children. One blended family 
with seven children. One A level education, two O level. 
All employed. Partners same educational and employment 
levels. Two own house (with mortgage), one rents from local 
authority.
Affected children 4–8 years old. All with ALL. 4–9 episodes of 
febrile neutropenia; 1–8 high-risk episodes each, 0–3 low-risk 
episodes each. All in POSCU (one later transferred to PTC). 
One admission to PICU after high-risk episode. Three delayed 
courses of chemo after high-risk episodes. Admissions 
2–14 days (most 48–72 hours).
Centre 3 Healthcare 
Professionals
3 0:3 30–
55 years
All White British One medical, two nursing (band 7). 3–12 years at current 
grade. 5–12 years at current centre.
ALL, Acute Lymphoblastic Leukaemia; GCSE, General Certiicate of Secondary Education; HNC, Higher National Certiicate; ICU, intensive care unit; 
ONC, Ordinary National Certiicate; PICU, paediatric intensive care unit; POSCU, Paediatric Oncology Shared Care Unit; PTC, primary treatment 
centre; SHO, Senior House Oficer.
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“Mod: …2660 episodes of data, how much more 
would people need to be more confident in this num-
ber (points to treatment failure rate)?
[ongoing discussion]
1: is that international?
Mod: yes it’s international around the world
2: so if it’s all round the world?
[additional discussion]
2: so actually you could say it’s a small number if it’s…
1: there’s the whole world…
2: yeah couldn’t you? and how many within each 
study? That would be the other thing
[further discussion]
1: because if the numbers were high, people would 
be more convinced that this is real, I think if er… 
you know I’d see, for instance this is just an example, 
if you had 500 000 episodes and then you saw this, 
you’d say yeah that’s it, this is what we need to go for 
(murmur of agreement from (2)) but two and a half 
thousand odd is not going to be convincing. (Centre 
2, doctor (1) and nurse (2))
Alongside these statistical misunderstandings, in all 
healthcare professional groups, there were moments 
within the discussion where comments made were incon-
sistent with other beliefs they held. In centre 2, one partic-
ipant stated “but if you look at the 0.1% risk [of PICU 
admission or death in low risk febrile neutropenia], it’s 
still high, in that group, because your range is between 
0.03% to 0.3%, and you’ve got 0.1%”. Considering a 0.1% 
risk of paediatric intensive care unit admission or death 
to be high seems unusual: in a field where 3% of chil-
dren with cancer die of infection and around 15% die of 
progressive disease.1 16
One method that healthcare professional participants 
used to help understand the risk statistics and express the 
inconsistency of their discussions was to compare the risks 
in febrile neutropenia to other clinical situations, both 
within the context of other haematology and oncology 
conditions and within other specialties, particularly 
general paediatrics.
Discussion by professionals about their own decision 
making revealed and acknowledged tension between 
making judgements based on research evidence and indi-
vidual emotional experience.
2: I think the interesting thing there for me [Mod] is 
that you’ve presented us with the evidence (laughter 
from others) which is by far and away saying that this 
is a safe thing to do…
4: we’ve chosen to ignore it…
2: but we’ve chosen to ignore it… so we’re practicing 
non-evidence based anecdotal medicine (ongoing 
laughter) but it’s what we’re comfortable with…
Mod: ok… so what factors played the role in making 
that decision…
2: non evidence based anecdotal…
4: anxiety…
(laughter and indiscernible mutterings) (Centre 1, 
doctor (2) and nurse (4))
In centre 3, professionals used fewer anecdotal accounts 
of patient deteriorations and appeared to have a less 
emotional, and more positive, response to early discharge.
Professional participants were very clear about the extent 
of influence that healthcare staff should have over families’ 
perceptions of risk. In the following quote, a participant 
outlines the dilemma of how to communicate about risk.
…and then you have to try and put the frighteners on 
them and you have to gauge that right as to how… be-
cause I’ve had people saying oh I… oh I know… we’ve 
got four hours to wait… and I say well sometimes chil-
dren deteriorate more rapidly than that…. erm… but 
it’s really difficult to know quite how… how scary to 
be with them isn’t it? (Centre 3, doctor)
Throughout this theme, it is clear that participants 
struggled with the uncertainty of risk. They sought the 
illusion of certainty, aiming to find security in the abso-
lute, irrespective of the reality of its non-existence. This 
may be founded in limited understanding or familiarity 
with statistical concepts. However, the assessment of risk 
is not a purely technical act but instead a political and 
social construct, with many underlying social, emotional 
and cultural influences.
Articulating and interpreting protocols
All the documents discussed in this manuscript are enti-
tled guidelines, suggesting flexibility in the use of their 
recommendations. However, participants used the word 
protocol almost exclusively and appeared to understand 
and use these documents as formal and rigid policies. We 
have used their terminology.
Although the direction given by protocols provided 
reassurance to healthcare professionals, protocols were 
interpreted as controlling and limited decisions by 
implying an inability to deviate from them, resulting in 
frustration:
1: I think the other thing that makes it frustrating its 
very protocol driven innit?
(2: (at the same time) yeah)
1: I think people stick rigidly to 48 hours as though 
it’s a magic number and nobody can go home at 
43 hours and etcetera… so I think it’s very very rig-
id err which is done for good reasons but I think if 
you dare to suggest that you veer from that you’re 
scorned upon… (Centre 1, doctors)
Professionals described risks of working outside the 
protocol, in particularly relating to receiving criticism 
from colleagues, with groups only briefly referring to 
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the safety risks to patients of deviating from a protocol. 
Notably, they referred to the risks to patients of other 
professionals departing from the protocol, but the risks 
of criticism refer to their own practice.
Participants varied in how much flexibility they thought 
there should be within a protocol. Centre 1 spoke of a 
strict protocol with minimal deviations and were willing 
to accept a greater degree of frustration because of this. 
Centre 2 gave considerable weight to clinical reviews, 
with minimal references to protocols as a guiding feature. 
Combining these approaches, professionals at centre 
3 spoke about the integration of protocol and clinical 
judgement:
1: like you’ve got the protocol there but actually if 
you know your patient… me and the consultant 
might make a decision on our patient that isn’t what 
the protocol says but we’re happy with that clinical 
decision (Centre 3, nurse)
Parents’ main concern regarding protocols related to 
the fact that discharge rarely occurred at the point where 
it was theoretically possible in the protocol. Parents distin-
guished between appropriate delays due to the child’s ill 
health and those which they felt were in some way avoid-
able. They voiced their frustration about how services, 
and decision making, were conditional on the timing of 
a child’s presentation with low-risk febrile neutropenia. 
The staff working out of hours may not be as senior or as 
experienced as those who provide routine services, and 
as such, parents recognised that they may make different 
judgements about the levels of risk involved or may not 
feel able to take on the responsibility of discharging a 
child.
Astutely, parents in a number of groups identified that 
blood culture results were a significant factor in profes-
sionals’ decision making in regard to discharge, and 
that most protocols demanded a negative blood culture 
result before a child could be evaluated for discharge. 
Delays in processing could result in substantial delays in 
decision making.
1: then my frustration comes with the process and 
blood culturing and that, towards the end of a stay, is 
what just really really narks me, that we actually spend 
at least an extra day in because they don’t culture the 
bloods when you get in straight away, so if we were 
admitted on Monday at noon or after, they don’t start 
culturing the bloods until Tuesday at 9am… (Centre 
3, parent of under 13 s)
Thus, blood cultures symbolise the potential for parents 
to ‘escape’ from hospital. Delays in obtaining results 
capture parents’ greatest dislike of current services and 
protocols; unnecessarily prolonged hospital stays with an 
apparently well child.
Preferences for care
Participants’ past experiences help to inform and find 
balance between the uncertainty of risks and the certainty 
of protocols. The findings outlined within this section 
all impacted on how participants formed their ideas 
regarding early discharge. Participants discussed many 
issues similar to those found in the earlier meta-ethnog-
raphy.11 Participants spoke of the tiring nature of travel-
ling, particularly at night time or during the rush hour. 
Distance from the hospital played a key role in whether 
early discharge regimens would be accepted, with fami-
lies living close to the treating hospital more likely to 
accept outpatient care. Participants in centre 3, barely 
mentioned travelling, presumably because they already 
live close to their treating POSCUs.
Parents discussed finances, related to travel, parking, 
hospital food and lost income. This was vividly described 
by some participants, including the loss of a self-run busi-
ness, repossession of a car and the receipt of benefits such 
as free school meals. The unpredictable nature of febrile 
neutropenia episodes proved more problematic than 
scheduled attendances for review or chemotherapy as it 
did not allow them to plan other aspects of their lives, 
chiefly their work.
Participants spoke about the psychological impact 
of admissions on their child who would become quiet, 
anxious or angry when their temperatures were checked 
at home, and they anticipated that they might need to 
travel to hospital. Following discharge, psychological 
effects would continue for some time:
1: we’re definitely a more stressed family when he’s 
admitted… definitely… and it takes a long time 
for the family to get back on track, it’s not just he’s 
home and we’re all fine, you actually have to com-
pletely collapse and rebuild and that takes a couple 
of days… (centre 3, parents of under 13 s)
Parents described split families, where one parent was 
in hospital with the affected child and the other at home 
with their siblings, with occasional ‘handovers’ of care, 
which impacted on their relationships as couples. The 
parent who took on the role of primary carer during 
admissions often had a deeper relationship with the child 
when they returned home as well, and the other parent 
could feel rejected or ‘worthless’. They expressed guilt 
over their choices when faced with the differing needs of 
their children.
Professionals mostly spoke about the experiences of 
families, with very few references to their own perspec-
tives, even when directly asked. They mentioned each of 
the key issues mentioned above but provided less detail 
and did not identify more nuanced issues about the 
patient experience. This situation resulted in double 
silencing of both parents and professional voices.
Six newly identified difficulties were discussed by 
participants in this study. First, all participants spoke 
clearly about how these are generally well children who 
are active, noisy and boisterous on a ward. They reported 
boredom and frustration during admissions and were 
concerned about their child disturbing other children 
who were more unwell. Second, parents worried about 
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‘hospital acquired infection’ and spoke about the risks of 
wards or hospitals which were not clean. Third, partici-
pants spoke about the impact of ‘source isolation’ in 
two ways. First, well children who are source isolated are 
usually even more bored or frustrated. Second, where 
source isolation beds are limited, participants knew that 
these are unavailable to sicker patients when children 
with low-risk febrile neutropenia are admitted. Parents 
expressed guilt for using these resources. Staff expanded 
on the issue of bed pressure (the fourth new difficulty), 
describing intense challenges faced by health services, 
where numbers of bed spaces are reduced and costs of 
bed occupancy are high.
The fifth challenge, discussed only by parents and 
young people, related to side effects of treatments, 
particularly diarrhoea caused by antibiotics, necessi-
tating source isolation, and might also cause the child 
to need intravenous fluids or total parenteral nutrition, 
delaying their discharge. Parents voiced a clear prefer-
ence for reduced amounts of antibiotics, particularly 
those given intravenously. In addition, parents spoke 
about concerns regarding antibiotic resistance and how 
this might impact on their child in the future. These 
issues were not raised in the healthcare professional 
discussions.
Sixth, healthcare professionals in centre 3 discussed the 
long-term psychological impact of current febrile neutro-
penic care.
…as a late effects nurse… the risk of repeated hos-
pitalisations and family seeing their child as sick and 
continuing to do so after the… and never really recov-
ering from that sick child mentality… I don’t know if 
that’s a bit strong… I see the late effect of that when 
you’ve still got families who haven’t been able to stop 
treating their child as a sick child right up until the 
child being in their early adulthood… I don’t know 
how you’d ever measure that to balance it against that 
0.1% risk… (Centre 3, nurse)
Three benefits of inpatient care were described. First, 
was the idea that hospital is a safe place, where profes-
sionals looked after their child’s health, though focused 
mainly on physical health. Parents stated that hospital was 
the place they would prefer their child to be if they judged 
them unwell. Families felt comforted by the presence of 
healthcare staff with whom they had good relationships 
and by the ritual of performing regular observations, 
although some groups did highlight that many observa-
tions could be done at home. Second, hospital can be 
fun. Young people and their parents enjoyed the input of 
youth support co-ordinators and activities that are organ-
ised in the hospital. This did not seem to play a major 
role in decision making, and parents were clear that they 
would still prefer a reduced therapy strategy. Third is the 
relational benefits that children and young people gained 
from the undivided attention of a parent, who, at home, 
might be distracted by other siblings and by the ‘hubbub’ 
of daily life.
When participants discussed the preferences of other 
participant groups, they often misunderstood perceived 
desires of others. For example, the young people antici-
pated that their parents would all rather receive inpatient 
care. This was at odds to the parents’ stated preferences
1: if my mum agreed with the doctors, then I’d just do 
what she said, cos they don’t like… when I’m saying 
something its normally cos it’s what I’d prefer, when 
my mum tells me to do something its what’s best for 
me… so… I’d probably whinge about having to stay-
ing in hospital but then… I’d just stay anyway.
2: I don’t know… I don’t think I’d really… I think my 
mum would just do what’s right for me. Yeah (Centre 
1, Young people)
dIsCussIOn
In summary, participants described a quest for certainty, in 
which they attempted to balance the uncertainty involved 
in understanding, expressing and negotiating risk with 
the illusion of certainty provided by strict protocols. Risks 
were assessed using both formal and informal stratifica-
tion tools, overlaid with the emotional reactions to risk and 
experiences of risk within other situations. Professionals 
in particular demonstrated more emotional responses 
than might have been anticipated, which appeared most 
associated with centre culture rather than age or experi-
ence. Understanding statistical expressions of risk proved 
challenging for patients, parents and healthcare profes-
sionals. Meanwhile, the benefits of certainty provided by 
protocols resulted in frustration at the strict constraints 
they mandated. The perceived benefits and harms of 
inpatient care that participants had previously experi-
enced informed their appraisals of future treatment strat-
egies and provided them with both more confidence in 
their risk assessments and a greater desire for flexibility 
within protocols.
Throughout this study, the differences in focus between 
families and healthcare professionals became apparent, 
particularly concerning health. Professionals had a 
limited focus on physical health, almost entirely on the 
prevention of an intensive care admission or death. 
Their focus on individual children was relatively narrow, 
though they had a broader focus on the number of fami-
lies impacted, taking into account the variety within their 
service population. Parents meanwhile focused on the 
broader aspects of child health, including side effects 
of interventions, social and emotional impacts and 
wider family health. However, they mostly concentrated 
on their individual child. Though they did discuss how 
others might differ in their opinions and desires when 
considering future services, it was the optimum regimen 
for their child and family that was put forward most 
strongly. These differences in objectives for future care 
are understandable given the responsibilities of families 
and healthcare professionals. However, stakeholders did 
not always understand each other’s priorities.
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Linked to this difference in focus on health, partic-
ipants discussed the most distressing aspects of being 
involved with children with febrile neutropenia differently 
according to their participant group. Healthcare profes-
sionals almost always discussed intensive care admission 
or death as their primary adverse experiences. Mean-
while, parents focused more on their experiences of poor 
care, such as delayed identification of positive culture 
growth, difficult venous access and the failure of profes-
sionals to identify what they perceived to be an unwell 
child. This highlights the differences in consideration of 
health between the two groups, while emphasising that 
many parents have no experience of death or intensive 
care admissions related to febrile neutropenia. Thus, 
their perceptions of risk of these events were somewhat 
different to those of professionals who often have expe-
rience of high-risk febrile neutropenia and thus develop 
strongly emotive reactions to suggestions of reductions in 
therapy. To families who experience more of the burdens 
of inpatient febrile neutropenia care, it is the failures to 
provide care focused on a holistic definition of health 
which play a more significant role in their experience.
These differences in focus further inform the interpre-
tation of our previous systematic review and of healthcare 
research in general.9 The review used outcomes, collected 
by the primary studies, that reflect the focus of health-
care professionals—intensive care, death and healthcare 
service usage, as opposed to those of the families receiving 
care. We now see that when primary research is designed 
by professionals to detect these outcomes and fails to take 
into account the experiences of care that families value, 
these outcomes are also hidden in secondary research. 
Future research design should involve more public and 
patient involvement in the outcome setting stage, and 
the interpretation of quantitative research should involve 
discussions with patients and families so as to gain more 
insight into the different viewpoints on specific statistical 
findings, dependent on prior experiences and consider-
ation of other benefits and harms.
Historically, determinism has shaped healthcare 
culture.17 In the deterministic worldview, predominant 
in early medicine, the role of physicians was to establish 
the definitive causes and treatments for disease. The 
clinician would strive to control each aspect of a patient’s 
health so as to have control over their outcomes.17 Deter-
minism inspires and promotes the creation of certainty, 
and thus where this cannot be achieved, the illusion of 
certainty can be considered a reasonable replacement as 
it provides a sense of control and reassurance within diffi-
cult situations. Understanding statistical risks and making 
decisions based on them is not prioritised, instead: “The 
goal is certainty, rather than learning how to live with 
uncertainty”.17
In contemporary healthcare, there is no certainty. 
Shared decision making has been suggested as an appro-
priate step in overcoming determinism, recognising 
differences in focus and beginning to respect the rights 
of patients to have autonomy over their healthcare 
decisions. Shared decision making is most suited to 
situations in which evidence shows little difference in 
outcomes between treatment options, and thus patients’ 
values or preferences might play a more important role in 
resolving this equipoise.18–21 In low-risk paediatric febrile 
neutropenia, evidence suggests that serious safety events 
are not affected by the location of care, and, as such, 
individualised judgements about other risks of readmis-
sion and patient preferences become more prominent.9 
Specifically, within the literature, there has been a drive 
to use shared decision making “where the balance of risks 
and benefits varies widely in different medical, social and 
health care situations”.18 Given the findings reported 
here, it might be considered that patients’ social circum-
stances, along with the individual psychological impact of 
admission, might lead to a different balance of risks and 
benefits for each family affected by paediatric low-risk 
febrile neutropenia.
Practically, one approach which may be particularly 
useful in stimulating shared decision making conversa-
tions is to routinely risk stratify all patients and commu-
nicate this risk to families, following education regarding 
the differences in risk groups and in the management 
of febrile neutropenia. This will be further facilitated by 
ongoing work by the Predicting Infectious Complications 
of Neutropenic sepsis In Children with Cancer collabora-
tion into the development of clear and robust risk strati-
fication rules, so that there is universal agreement on the 
definition of children at low risk of septic complications.
strengths and weaknesses
This study involves new voices in the discussion of febrile 
neutropenia management, particularly healthcare profes-
sionals and deepened consideration of the disease-spe-
cific factors which influence stakeholders’ experiences 
and inform their decisions about future care. The inclu-
sion of multiple centres allows for an understanding of 
the impact of service design and centre culture on partic-
ipants’ perceptions.
The majority of the challenges relate to recruitment 
difficulties, particularly of young people and those who 
have a limited ability to communicate in English. This 
reflects broader problems within the research community 
of engaging with participants from social disadvantaged 
groups and those from multicultural contexts.22 23 Intro-
ducing Amazon vouchers to compensate participants for 
their time resulted in improvements in recruitment of 
young people and thus have helped to reduce the short-
comings. Future studies may wish to integrate other meth-
odologies, including interviews or online focus groups 
for those who do not wish to participate in face-to-face 
groups, as well as options to participate using different 
languages for those who are unable to confidently take 
part in English language focus groups.
The small size of some of the focus groups may be 
considered a limitation by some as they may lead to less 
extensive discussions, and shy or dominating participants 
may have a more acute effect on the group. However, 
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smaller groups have been purported to be beneficial in 
discussions involving complex subjects, or in groups of 
experts, such as healthcare professionals, and thus we feel 
are not a substantial disadvantage in this setting.22 24 25
COnClusIOns
This study highlights the previously underestimated 
harms of admission for febrile neutropenia and the 
paternalistic nature of decision making, along with 
the frustrations and challenges for all parties involved 
in febrile neutropenia care. It justifies a reassessment 
of current treatment strategies for these children and 
further exploration of the potential to introduce shared 
decision making.
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